glp-1 shortage us FDA restricts non-approved compounded weight loss products FDA says shortage of GLP-1

Like obstructions of the small intestine, bowel obstructions could lead to tissue death, peritonitis, or sepsis without proper treatment

Many of the companies have started offering GLP-1 medications for weight loss as demand for these drugs has exploded

The shares are higher among uninsured adults (41%), Hispanic adults (33%), Black adults (32%), and those with annual household incomes below $40,000 (33%)

Brands like Ozempic and Wegovy are a semaglutide (GLP-1 RA)

Double Serving (4 teaspoons) Delivers a 10 gram boost of fiber for those seeking maximum benefits, including increased GLP-1 release, up to two times the normal amount (when taken with a meal)